Stock GLSI GREENWICH LIFESCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Greenwich LifeSciences, Inc.

Equities

GLSI

US3968791083

Delayed Nasdaq
Other stock markets
 09:36:35 2024-04-26 am EDT 		5-day change 1st Jan Change
12.75 USD +3.32% Intraday chart for Greenwich LifeSciences, Inc. +5.63% +21.20%
Apr. 15 Greenwich LifeSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 11 North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge DJ

Evolution of the average Target Price on Greenwich LifeSciences, Inc.

Price target over the last 5 years

History of analyst recommendation changes

d0a5d16f0a6e07257e4874453cbfe.fPXIAMLX31F3mKyIjh4FCd9Q8MCDTCrE8roQN7cMWHY.I7yCUrDvsWUH6e_a331pOLEmhLDFOB21nehjQ9Z1LTtPqqdorK2sNRTv4Q~18356a9ad2eba8d8de767a44254e175c

Analyst Recommendations on Greenwich LifeSciences, Inc.

HC Wainwright Adjusts Greenwich LifeSciences Price Target to $36 From $38, Maintains Buy Rating MT
HC Wainwright Cuts Greenwich LifeSciences' Price Target to $38 From $78, Keeps Buy Rating MT
GREENWICH LIFESCIENCES : HC Wainwright Starts Greenwich LifeSciences at Buy with $78 Price Target MT
GREENWICH LIFESCIENCES : Aegis Capital Initiates Coverage on Greenwich LifeSciences at Buy Rating, Sets Price Target at $75 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
12.34 USD
Average target price
36 USD
Spread / Average Target
+191.73%
High Price Target
36 USD
Spread / Highest target
+191.73%
Low Price Target
36 USD
Spread / Lowest Target
+191.73%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Greenwich LifeSciences, Inc.

HC Wainwright
Aegis Capital

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. GLSI Stock
  4. Consensus Greenwich LifeSciences, Inc.